- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/46 - 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
Patent holdings for IPC class A61K 31/46
Total number of patents in this class: 1216
10-year publication summary
|
97
|
84
|
119
|
88
|
105
|
107
|
116
|
105
|
72
|
24
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
41 |
| Boehringer Ingelheim International GmbH | 4629 |
39 |
| Theravance Biopharma R&D IP, LLC | 550 |
33 |
| Saniona A/S | 47 |
26 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 790 |
25 |
| Sydnexis, Inc. | 47 |
25 |
| Neurosearch A/S | 222 |
24 |
| Vyluma Inc. | 35 |
14 |
| Noden Pharma Designated Activity Company | 14 |
14 |
| Cipla Limited | 469 |
13 |
| The Regents of the University of California | 18943 |
12 |
| Janssen Pharmaceutica N.V. | 3839 |
12 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
12 |
| Incelldx, Inc. | 48 |
11 |
| Theravance, Inc. | 93 |
10 |
| ACADIA Pharmaceuticals Inc. | 201 |
9 |
| Chase Pharmaceuticals Corporation | 37 |
9 |
| Shanghai Haiyan Pharmaceutical Technology Co. Ltd | 100 |
9 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
9 |
| Merck Sharp & Dohme LLC | 3689 |
9 |
| Other owners | 860 |